Q9H8M2 (BRD9_HUMAN) Homo sapiens (Human)
Bromodomain-containing protein 9 UniProtKBInterProSTRINGInteractive Modelling
Available Structures
48 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Crystal structure of BRD9 Bromodomain bound to a butyryllysine peptide |
Heteromer P62805; | 100 | ||||
| Crystal structure of BRD9 Bromodomain bound to a crotonyllysine peptide |
Heteromer P62805; | 100 | ||||
| Crystal structure of BRD9 Bromodomain bound to a crotonyllysine peptide |
Heteromer P62805; | 100 | ||||
| Crystal structure of BRD9 Bromodomain bound to a crotonyllysine peptide |
Heteromer P62805; | 100 | ||||
| Crystal structure of BRD9 Bromodomain bound to a butyryllysine peptide |
Heteromer P62805; | 100 | ||||
| Crystal structure of BRD9 Bromodomain bound to an acetylated peptide |
Heteromer P62805; | 100 | ||||
| Crystal structure of BRD9 Bromodomain bound to a butyryllysine peptide |
Heteromer P62805; | 100 | ||||
| Crystal structure of human bromodomain containing 9 isoform 1 (BRD9) | homo-2-mer | 97.17 | ||||
| Crystal structure of the bromodomain of human BRD9 in complex with bromosporine (BSP) | homo-2-mer | 97.17 | 2×BMF; | |||
| Crystal structure of human BRD9 bromodomain in complex with LP99 chemical probe | homo-2-mer | 97.17 | 2×6B2; | |||
| Crystal structure of BRD9 bromodomain in complex with an indolizine ligand | homo-2-mer | 97.17 | 2×5L0; 2×EDO; | |||
| Crystal structure of the bromodomain of human BRD9 bound to TG003 | homo-2-mer | 97.17 | 2×EAE; | |||
| Crystal Structure of BRD9 bromodomain | monomer | 100 | 1×7P7; | |||
| Structure of the BRD9 bromodomain and compound 27 | monomer | 97.2 | 1×OEZ; 2×EDO; 2×NA; | |||
| Crystal structure of the bromodomain of human BRD9 bound to I-BRD9 | monomer | 97.2 | 1×EDO; 1×H1B; | |||
| Structure of the BRD9 bromodomain and compound 2 | monomer | 97.2 | 1×OF8; 1×EDO; | |||
| Crystal Structure of the bromodomain of human BRD9 in complex with a triazolo-phthalazine ligand | monomer | 97.2 | 1×Y1Z; | |||
| Structure of the BRD9 bromodomain and TP-472 | monomer | 97.2 | 1×QMG; | |||
| Structure of the BRD9 bromodomain and compound 11 | monomer | 97.2 | 1×OFK; 4×EDO; | |||
| Crystal structure of the BRD9 bromodomain with BI-7189 | monomer | 97.17 | 1×M2O; | |||
| Structure of the BRD9 bromodomain and compound 15 | monomer | 97.17 | 1×OF5; | |||
| CRYSTAL STRUCTURE OF BRD9 IN COMPLEX WITH BI-7273 | monomer | 97.17 | 1×5SW; | |||
| Crystal structure of the BRD9 bromodomain in complex with compound 4. | monomer | 97.17 | 1×5TU; | |||
| Crystal Structure of the bromodomain of BRD9 in complex with a 2-amine-9H-purine ligand | monomer | 97.17 | 1×43U; 1×BR; | |||
| Crystal structure of BRD9 bromodomain in complex with a valerolactam quinolone ligand | monomer | 97.17 | 1×4L2; | |||
| Crystal structure of the BRD9 bromodomain in complex with compound 3. | monomer | 97.17 | 1×5TY; | |||
| Crystal structure of the BRD9 bromodamian in complex with BI-9564. | monomer | 97.17 | 1×5U6; | |||
| Crystal structure of BRD9 bromodomain in complex with a substituted valerolactam quinolone ligand | monomer | 97.17 | 1×4L3; | |||
| Crystal structure of the bromodomain of BRD9 in complex with compound 9. | monomer | 97.17 | 1×5U2; | |||
| Crystal structure of human BRD9 bromodomain in complex with a PROTAC | monomer | 97.17 | 1×GBW; | |||
| Crystal structure of the unliganded bromodomain of human BRD9 | monomer | 99.04 | 1×SO4; 2×EDO; 1×DMS; | |||
| BRD9 bromodomain in complex with 3-(6-(but-3-en-1-yl)-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-… | monomer | 100 | 1×67C; | |||
| BRD9 in complex with Cpd1 (6-methyl-1,6-dihydro-7H-pyrrolo[2,3-c]pyridin-7-one) | monomer | 100 | 4×EDO; 1×PEG; 1×67N; | |||
| Crystal structure of the bromodomain of human BRD9 bound to TP472 | monomer | 100 | 1×QMG; 1×EDO; | |||
| BRD9 in complex with Cpd2 (N,N-dimethyl-3-(6-methyl-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-yl… | monomer | 100 | 1×67B; | |||
| BROMODOMAIN OF HUMAN BRD9 WITH 7-(3,4-dimethoxyphenyl)-2-(4- methanesulfonylpiperazine-1-carbonyl)-… | monomer | 100 | 1×N1D; | |||
| BRD9 in complex with Cpd4 ((E)-3-(6-(but-2-en-1-yl)-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-yl… | monomer | 100 | 1×69G; | |||
| Crystal structure of BRD9 Bromodomain bound to DMSO | monomer | 100 | 1×DMS; | |||
| BRD9 with 4-chloro-2-methyl-methylamino-pyridazinone | monomer | 100 | 1×82I; | |||
| BROMODOMAIN OF HUMAN BRD9 WITH 7-(3,4-dimethoxyphenyl)-N-(1,1-dioxo-1- thian-4-yl)-5-methyl-4-oxo-4… | monomer | 100 | 1×TVU; | |||
| BROMODOMAIN OF HUMAN BRD9 WITH 4-chloro-2-methyl-5-((2-methyl-1,2,3,4-tetrahydroisoquinolin-5-yl)am… | monomer | 100 | 2×I0D; | |||
| BRD9 with methylpiperazinyl-benzyl-amino-dimethylpyridazinone | monomer | 100 | 1×P8Z; | |||
| BRD9 with Biphenyl-methylamino-dimethylpyridazinone | monomer | 100 | 1×P8W; | |||
| BROMODOMAIN OF HUMAN BRD9 WITH N-(1,1-dioxo-1-thian-4-yl)-5-methyl-4- oxo-7-3-(trifluoromethyl)phen… | monomer | 100 | 1×EDO; 1×XZB; | |||
| BROMODOMAIN OF HUMAN BRD9 WITH N-(1,1-dioxo-1-thian-4-yl)-5-ethyl-4- oxo-7-3-(trifluoromethyl)pheny… | monomer | 100 | 1×EDO; 1×H1B; | |||
| Crystal structure of BRD9 bromodomain in complex with compound EA-89 | monomer | 100 | 1×L8L; | |||
| Crystal structure of the BRD9 bromodomain and hit 1 | monomer | 100 | 1×6KT; | |||
| Crystal structure of the bromodomain of human BRD9 bound to sunitinib | monomer | 100 | 1×B49; | |||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 6hm0.1.A | monomer | 0.61 | 1×GBW; | 97.27 | ||
5 SWISS-MODEL models built on isoform sequence
| Isoform | Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|---|
| Isoform 1 | 3hme.1.A | monomer | 0.74 | 100.00 | |||
| Isoform 2 | 1sum.1.A | monomer | 0.54 | 17.24 | |||
| Isoform 3 | 4n3w.1.A | monomer | 0.66 | 28.85 | |||
| Isoform 4 | 5twx.1.A | monomer | 0.75 | 1×7P7; | 100.00 | ||
| Isoform 6 | 4xy8.1.A | monomer | 0.55 | 1×43U; 1×BR; | 95.51 | ||